Latest Articles on Lung Cancer
Lung Cancer
Breaking prejudice in lung cancer
“Did you smoke?”: Time to rethink the impact of this question on lung cancer patients.
Read more
Lung Cancer
Our goal of transforming DLL3-positive carcinomas
Our progress in developing a potential targeted immunotherapy for DLL3-positive small cell lung cancer and neuroendocrine carcinomas.
Read more
Lung Cancer
Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting for 80-85% of all lung cancer cases. Find out more about testing and treatment here.
Read more
Related Press Releases
September 02, 2020
Final analysis of the observational GioTag study: Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer
March 16, 2020
New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib
Links
Welcome to InOncology.com
A knowledge hub providing information and education in oncology for healthcare professionals.
Nintedanib (Vargatef) in Oncology
A treatment for adenocarcinoma
Afatinib (Giotrif)
A treatment for EGFR M+ NSCLC
Downloads
Nintedanib in Oncology
Explore nintedanib’s mode of action and role in the treatment of lung cancer (PDF).